204 related articles for article (PubMed ID: 16762272)
1. [Preoperative serum CA15.3 and CEA levels and clinical-biological parameters in breast tumors].
Ruibal A; Garrido Pumar M; Arias JI
Rev Esp Med Nucl; 2006; 25(3):180-3. PubMed ID: 16762272
[TBL] [Abstract][Full Text] [Related]
2. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
[TBL] [Abstract][Full Text] [Related]
3. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
4. [Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers].
Ruibal A; Garrido-Pumar M; Arias JI
Rev Esp Med Nucl; 2006; 25(1):15-9. PubMed ID: 16540006
[TBL] [Abstract][Full Text] [Related]
5. [Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations].
Ruibal A; Arias J; Del Río MC; Resino C; Tejerina A
Rev Esp Med Nucl; 2001 Dec; 20(7):525-9. PubMed ID: 11709137
[TBL] [Abstract][Full Text] [Related]
6. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].
Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A
Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070
[TBL] [Abstract][Full Text] [Related]
7. CA 15-3 serum levels in patients with ductal breast carcinoma: relationship with clinicopathological parameters and tumor markers.
González-Sistal A; Arias JI; Ruibal A
Int J Biol Markers; 2012; 27(1):47-52. PubMed ID: 21928245
[TBL] [Abstract][Full Text] [Related]
8. [Clinico-biological impact of pS2 positivity in estrogen receptor negative-infiltrating ductal carcinomas of the breast].
Ruibal A; Arias J; del Río MC; San Román JM; Lapeña G; Pardo C; Tejerina A
Rev Esp Med Nucl; 2000 Oct; 19(6):428-33. PubMed ID: 11060273
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer.
Wu SG; He ZY; Zhou J; Sun JY; Li FY; Lin Q; Guo L; Lin HX
Breast; 2014 Feb; 23(1):88-93. PubMed ID: 24291374
[TBL] [Abstract][Full Text] [Related]
10. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.
Arslan N; Serdar M; Deveci S; Ozturk B; Narin Y; Ilgan S; Ozturk E; Ozguven MA
Ann Nucl Med; 2000 Oct; 14(5):395-9. PubMed ID: 11108173
[TBL] [Abstract][Full Text] [Related]
11. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
[TBL] [Abstract][Full Text] [Related]
12. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
13. Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer.
Zhao W; Li X; Wang W; Chen B; Wang L; Zhang N; Wang Z; Yang Q
Dis Markers; 2021; 2021():5529106. PubMed ID: 34621407
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative CA15.3 serum levels and cellular proliferation in patients having infiltrating ductal carcinomas of the breast].
Ruibal A; Sánchez Salmón A; Garrido M; Bogdan Ciobotaru A; Arias JI
Rev Esp Med Nucl; 2007; 26(6):367-71. PubMed ID: 18021691
[TBL] [Abstract][Full Text] [Related]
15. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
16. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
[TBL] [Abstract][Full Text] [Related]
17. [Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].
Ruibal A; Arias J; Lapeña G; García Díez S; Tejerina A
Rev Esp Med Nucl; 2001 Jun; 20(4):332-3. PubMed ID: 11940423
[No Abstract] [Full Text] [Related]
18. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
